Cancer risks with JAKi and biological disease-modifying antirheumatic drugs in patients with rheumatoid arthritis or psoriatic arthritis: a national real-world cohort study.

Viking Huss Hannah Bower Karin Hellgren Thomas Frisell Johan Asklingnull nullnull null

Published in: Annals of the rheumatic diseases (2023)

In clinical practice, the short-term risk of cancer other than NMSC in individuals initiating treatment with JAKi is not higher than for TNFi, but we found evidence of increased risk for NMSC.

Keyphrases

papillary thyroid
clinical practice
squamous cell
rheumatoid arthritis
lymph node metastasis
childhood cancer
quality improvement
risk assessment
human health
climate change
rheumatoid arthritis patients
drug induced